Article Details
Retrieved on: 2021-01-07 02:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Under the terms of the agreement, ImaginAb will supply clinical doses of 89Zr CD8 Immuno-PET agent to Pfizer for use in select oncology clinical trials ...
Article found on: www.prnewswire.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here